These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Factors associated with the presence of nonalcoholic steatohepatitis in patients with chronic hepatitis C. Solis-Herruzo JA; Pérez-Carreras M; Rivas E; Fernández-Vázquez I; Garfia C; Bernardos E; Castellano G; Colina F Am J Gastroenterol; 2005 May; 100(5):1091-8. PubMed ID: 15842583 [TBL] [Abstract][Full Text] [Related]
7. Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis. Zuin J; Veggiani G; Pengo P; Gallotta A; Biasiolo A; Tono N; Gatta A; Pontisso P; Toth R; Cerin D; Frecer V; Meo S; Gion M; Fassina G; Beneduce L Clin Chem Lab Med; 2010 Feb; 48(2):217-23. PubMed ID: 20001440 [TBL] [Abstract][Full Text] [Related]
8. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: A prospective study. Biasiolo A; Trotta E; Fasolato S; Ruvoletto M; Martini A; Gallotta A; Fassina G; Angeli P; Gatta A; Pontisso P Dig Liver Dis; 2016 Feb; 48(2):197-202. PubMed ID: 26614642 [TBL] [Abstract][Full Text] [Related]
10. Evidence for a role of nonalcoholic steatohepatitis in hepatitis C: a prospective study. Bedossa P; Moucari R; Chelbi E; Asselah T; Paradis V; Vidaud M; Cazals-Hatem D; Boyer N; Valla D; Marcellin P Hepatology; 2007 Aug; 46(2):380-7. PubMed ID: 17659580 [TBL] [Abstract][Full Text] [Related]
11. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma. Pontisso P; Quarta S; Caberlotto C; Beneduce L; Marino M; Bernardinello E; Tono N; Fassina G; Cavalletto L; Gatta A; Chemello L Int J Cancer; 2006 Aug; 119(4):735-40. PubMed ID: 16550605 [TBL] [Abstract][Full Text] [Related]
12. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C. Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC). Pozzan C; Cardin R; Piciocchi M; Cazzagon N; Maddalo G; Vanin V; Giacomin A; Pontisso P; Cillo U; Farinati F J Gastroenterol Hepatol; 2014 Aug; 29(8):1637-44. PubMed ID: 24635038 [TBL] [Abstract][Full Text] [Related]
14. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma. Beneduce L; Castaldi F; Marino M; Quarta S; Ruvoletto M; Benvegnù L; Calabrese F; Gatta A; Pontisso P; Fassina G Cancer; 2005 Jun; 103(12):2558-65. PubMed ID: 15887222 [TBL] [Abstract][Full Text] [Related]
15. SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. Fransvea E; Trerotoli P; Sacco R; Bernabucci V; Milella M; Napoli N; Mazzocca A; Renna E; Quaranta M; Angarano G; Villa E; Antonaci S; Giannelli G J Viral Hepat; 2012 Oct; 19(10):704-10. PubMed ID: 22967101 [TBL] [Abstract][Full Text] [Related]
16. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117 [TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time? Montagnana M; Danese E; Lippi G Clin Chim Acta; 2015 May; 445():161-6. PubMed ID: 25840050 [TBL] [Abstract][Full Text] [Related]
18. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients. Guarino M; Di Costanzo GG; Gallotta A; Tortora R; Paneghetti L; Auriemma F; Tuccillo C; Fassina G; Caporaso N; Morisco F Scand J Clin Lab Invest; 2017 Oct; 77(6):448-453. PubMed ID: 28609160 [TBL] [Abstract][Full Text] [Related]
19. Histological features of chronic hepatitis C in haemodialysis patients. Sakellariou S; Boletis JN; Sypsa V; Psichogiou M; Tiniakos D; Delladetsima I Liver Int; 2014 Jul; 34(6):e56-61. PubMed ID: 25234282 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor alpha L162V polymorphism in nonalcoholic steatohepatitis and genotype 1 hepatitis C virus-related liver steatosis. Verdi H; Koytak ES; Onder O; Ergül AA; Cinar K; Idilman R; Erden E; Bozdayi AM; Yurdaydin C; Uzunalimoglu O; Bozkaya H J Investig Med; 2005 Nov; 53(7):353-9. PubMed ID: 16297361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]